Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • zee
    NGS specialist
    • Apr 2008
    • 249

    OpenGE on Redhat

    Hi

    I am trying to get the openGE binaries working on Redhat enterprise machines. openge fails with the following error:


    Code:
    openge: symbol lookup error: openge: undefined symbol: _ZZN8BamTools12IBamIODevice14SetErrorStringERKSsS2_E9SEPARATOR
    I am using Redhat 6, linux 64-bit.

    Code:
    Linux 2.6.18-238.el5 #1 SMP Sun Dec 19 14:22:44 EST 2010 x86_64 x86_64 x86_64 GNU/Linux
    Is there something I am missing?
  • adaptivegenome
    Super Moderator
    • Nov 2009
    • 436

    #2
    We tested the binaries on an EC2 image of RHEL. It works fine there. However, we will take a look at a local installation of RedHat to see if we can reproduce the error as we would like users to be able to get going with the binaries.

    In the worst case, you would have to install zlib, boost, and bamtools; and then compile from source.

    Hopefully by the next release we can supplement the binaries with RPM and DEB packages. Should make install easier.

    Comment

    • adaptivegenome
      Super Moderator
      • Nov 2009
      • 436

      #3
      We now have an RPM for OpenGE! Send me a direct PM and ill share it with you. The next release of OpenGE will feature source, binaries, RPM, and DEB.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      34 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      217 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      81 views
      0 reactions
      Last Post SEQadmin2  
      Working...